Results 61 to 70 of about 24,035 (181)
Human Vaccines & Immunotherapeutics, 2019 Introduction: Bacterial meningitis is one of the leading causes of morbidity and mortality among children and adults. Better understanding of the seroepidemiology of meningitis is critical for both the selection and implementation of an effective ...
Meltem Dinleyici +5 more
doaj +1 more source
Meningococcal Vaccines: Current Status and Emerging Strategies
Vaccines, 2018 Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy +2 more
doaj +1 more source
Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign. [PDF]
PLoS ONE, 2017 Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saharan Africa. In 2010, Burkina Faso became the first country to implement a national meningococcal serogroup A conjugate vaccine (MACV) campaign.
Alpha Oumar Diallo +14 more
doaj +1 more source
Journal of Renal Care, Volume 51, Issue 4, December 2025.ABSTRACT Background Haemodialysis patients face an elevated risk of infectious diseases due to immunosuppression and frequent exposure to healthcare settings. Vaccination is a critical preventive strategy for this population; however, coverage remains inconsistent across different vaccines.
Eirini Potamianou +6 more
wiley +1 more source
Emergence and genomic diversification of a virulent serogroup W:ST-2881(CC175) Neisseria meningitidis clone in the African meningitis belt. [PDF]
, 2017 Countries of the African 'meningitis belt' are susceptible to meningococcal meningitis outbreaks. While in the past major epidemics have been primarily caused by serogroup A meningococci, W strains are currently responsible for most of the cases.
Abdul Sater, Mohamad R +12 more
core +1 more source
American Journal of Hematology, Volume 100, Issue 11, Page 2040-2051, November 2025.ABSTRACT Inappropriate complement activation is a key driver of hematopoietic cell transplant‐associated thrombotic microangiopathy (TA‐TMA). Treatment with narsoplimab, an inhibitor of MASP‐2, the effector enzyme of the lectin pathway, resulted in a response rate of 61% in a Phase 2 clinical trial in adults with TA‐TMA.
Michelle L. Schoettler +6 more
wiley +1 more source
Risk of transmitting meningococcal infection by transient contact on aircraft and other transport. [PDF]
, 2009 Contact tracing of persons with meningococcal disease who have travelled on aeroplane or other multi-passenger transport is not consistent between countries.
Hellenbrand, W +4 more
core +3 more sources
Human Vaccines & ImmunotherapeuticsWide use of the groundbreaking vaccine MenAfriVac® has eliminated serogroup A meningococcal meningitis in the African meningitis belt and paved the way for elimination of all meningococcal disease outbreaks with the development, licensure, and ...
Mark R. Alderson +7 more
doaj +1 more source
The Silent Risk of Sudan Virus: A Review Addressing Global Health Vulnerabilities
Health Science Reports, Volume 8, Issue 11, November 2025.ABSTRACT Background and Aim Sudan Virus Disease (SVD) is a deadly hemorrhagic fever caused by the Sudan virus, first discovered in Sudan in 1976. This disease has been linked to several outbreaks in sub‐Saharan Africa, particularly in Uganda. The high fatality rate of SVD, ranging from 41% to 70%, emphasizes the critical need for effective preventive ...
Syed Masudur Rahman Dewan +1 more
wiley +1 more source
Development of Multi-Locus Variable Number Tandem Repeat Analysis for Outbreak Detection of Neisseria meningitidis [PDF]
, 2006 Neisseria meningitidis is a major cause of septicemia and meningitis worldwide. Traditional typing methods like pulsed-field gel electrophoresis (PFGE) for identifying outbreaks are subjective and time consuming.
Price, Alicia Anne
core